Molecular pathophysiology of Bartter’s and Gitelman’s syndromes

详细信息    查看全文

• 作者：Efstathios Koulouridis ; Ioannis Koulouridis
• 关键词：Bartter’s syndrome ; calcium reabsorption ; Gitelman’s syndrome ; magnesium reabsorption ; salt loosing tubulopathies
• 刊名：World Journal of Pediatrics
• 出版年：2015
• 出版时间：May 2015
• 年：2015
• 卷：11
• 期：2
• 页码：113-125
• 全文大小：888 KB
• 参考文献：1.Bartter FC, Pronove P, Gill JR Jr, Maccardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med 1962;33:811-28.View Article PubMed
  2.Gitelman HJ, Graham JB, Welt LG. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 1966;79:221-35.PubMed
  3.Rudin A. Bartter’s syndrome. A review of 28 patients followed for 10 years. Acta Med Scand 1988;224:165-71.View Article PubMed
  4.Ji W, Foo JN, O’Roak BJ, Zhao H, Larson MG, Simon DB, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 2008;40:592-99.View Article PubMed Central PubMed
  5.Knoers NV, Levtchenko EN. Gitelman syndrome. Orphanet J Rare Dis 2008;3:22.View Article PubMed Central PubMed
  6.Stein JH. The pathogenetic spectrum of Bartter’s syndrome. Kidney Int 1985;28:85-3.View Article PubMed
  7.Fremont OT, Chan JC. Understanding Bartter syndrome and Gitelman syndrome. World J Pediatr 2012;8:25-0.View Article PubMed
  8.Kurtz I. Molecular pathogenesis of Bartter’s and Gitelman’s syndromes. Kidney Int 1998;54:1396-410.View Article PubMed
  9.Unwin RJ, Capasso G. Bartter’s and Gitelman’s syndromes: their relationship to the actions of loop and thiazide diuretics. Curr Opin Pharmacol 2006;6:208-13.View Article PubMed
  10.Gamba G, Saltzberg SN, Lombardi M, Miyanoshita A, Lytton J, Hediger MA, et al. Primary structure and functional expression of a cDNA encoding the thiazide-sensitive, electroneutral sodium-chloride cotransporter. Proc Natl Acad Sci U S A 1993;90:2749-753.View Article PubMed Central PubMed
  11.Gamba G, Miyanoshita A, Lombardi M, Lytton J, Lee WS, Hediger MA, et al. Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride cotransporter family expressed in kidney. J Biol Chem 1994;269:17713-7722.PubMed
  12.Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, et al. Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 1996;12:24-0.View Article PubMed
  13.Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP. Bartter’s syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 1996;13:183-88.View Article PubMed
  14.Simon DB, Karet FE, Rodriguez-Soriano J, Hamdan JH, DiPietro A, Trachtman H, et al. Genetic heterogeneity of Bartter’s syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet 1996;14:152-56.View Article PubMed
  15.Dimke H, Hoenderop JG, Bindels RJ. Hereditary tubular transport disorders: implications for renal handling of Ca2+ and Mg2+. Clin Sci (Lond) 2009;118:1-8.View Article
  16.Nascimento CL, Garcia CL, Schvartsman BG, Vaisbich MH. Treatment of Bartter syndrome. Unsolved issue. J Pediatr (Rio J) 2014;90:512-17.View Article
  17.Blanchard A, Vargas-Poussou R, Vallet M, Caumont-Prim A, Allard J, Desport E, et al. Indomethacin, Amiloride, or Eplerenone for Treating Hypokalemia in Gitelman Syndrome. J Am Soc Nephrol 2014 Jul 10. [Epub ahead of print]
  18.Rose BD. Diuretics. Kidney Int 1991;39:336-52.View Article PubMed
  19.Dimke H, Hoenderop JG, Bindels RJ. Molecular basis of epithelial Ca2+ and Mg2+ transport: insights from the TRP channel family. J Physiol 2011;589:1535-542.View Article PubMed Central PubMed
  20.Greger R, Schlatter E. Presence of luminal K+, a prerequisite for active NaCl transport in the cortical thick ascending limb of Henle’s loop of rabbit kidney. Pflugers Arch 1981;392:92-4.View Article PubMed
  21.Ares GR, Caceres PS, Ortiz PA. Molecular regulation of NKCC2 in the thick ascending limb. Am J Physiol Renal Physiol 2011;301:F1143–F1159.View Article PubMed Central PubMed
  22.Haisch L, Almeida JR, Abreu da Silva PR, Schlingmann KP, Konrad M. The role of tight junctions in paracellular ion transport in the renal tubule: lessons learned from a rare inherited tubular disorder. Am J Kidney Dis 2011:57:320-30.View Article PubMed
  23.Planells-Cases R, Jentsch TJ. Chloride channelopathies. Biochim Biophys Acta 2009;1792:173-89.View Article PubMed
  24.Scholl U, Hebeisen S, Janssen AG, Müller-Newen G, Alekov A, Fahlke C. Barttin modulates trafficking and function of ClC-K channels. Proc Natl Acad Sci U S A 2006;103:11411-1416.View Article PubMed Central PubMed
  25.Biner HL, Arpin-Bott MP, Loffing J, Wang X, Knepper M, Hebert SC, et al. Human cortical distal nephron: distribution of electrolyte and water transport pathways. J Am Soc Nephrol 2002;13:836-47.PubMed
  26.Gamba G. The thiazide-sensitive Na+-Cl?/sup> cotransporter: molecular biology, functional properties, and regulation by WNKs. Am J Physiol Renal Physiol 2009;297:F838–F848.View Article PubMed Central PubMed
  27.Hoenderop J
• 作者单位：Efstathios Koulouridis (1)
  Ioannis Koulouridis (2)
  
  1. Nephrology Department, General Hospital of Corfu, Corfu, Greece
  2. St. Elizabeth’s Medical Center, Boston, USA
  
• 刊物主题：Pediatrics; Pediatric Surgery; Maternal and Child Health; Intensive / Critical Care Medicine; Surgery; Imaging / Radiology;
• 出版者：Springer Berlin Heidelberg
• ISSN：1867-0687

文摘

Background In the last two decades, progress in cytogenetic and genome research has enabled investigators to unravel the underlying molecular mechanisms of inherited tubulopathies such as Bartter’s and Gitelman’s syndromes and helped physicians to better understand not only these two pathologic entities but also renal pathophysiology and salt sensitive hypertension. Data sources Articles collected from PubMed and open access journals included original articles, research articles, and comprehensive reviews. They were evaluated by the authors with an special emphasis on originality and up to date information about molecular pathophysiology. Results Bartter’s and Gitelman’s syndromes are two different inherited salt loosing tubulopathies. They are characterized by various inability of distal nephron to reabsorb sodium chloride with resultant extarcellular volume contraction and increased activity of the renin angiotensin aldosterone system. Hypokalemic metabolic alkalosis is a common feature of these two forms of tubulopathies. Hypercalciuria characterizes the majority of Bartter’s syndrome, and hypomagnesemia with hypocalciuria characterizes Gitelman’s syndrome. Low blood pressure is a common feature among patients who suffered from these tubulopathies. Bartter’s syndromes encompass a heterogeneous group of ion channels defects localized at the thick ascending limp of Henle’s loop with resultant loss of function of sodium-potassium-2 chloride cotransporter. These defects result in the impairment of the countercurrent multiplication system of the kidney as well as calcium, potassium and acid base disturbances which in the majority of cases are proved lethal especially in the antenatal and/or immediate postnatal life period. The underlying pathology in Gitelman’s syndrome is defined to the distal convoluted tubule and is related to loss of function of the sodium-chloride cotransporter. The results of this defect encompass the inability of extracellular volume homeostasis, magnesium and potassium conservation, and acid base disturbances which are generally mild and in the majority of cases are not life-threatening. Conclusions Recent advances in molecular pathophysiology of Bartter’s and Gitelman’s syndromes have helped physicians to better understand the underlying mechanisms of these pathologic entities which remain obscure. Data collected from experiments among genetically manipulated animals enable us to better understand the pathophysiology of mammalian kidney and the underlying mechanisms of salt sensitive hypertension and to lay a foundation for the future development of new drugs, especially diuretics and antihypertensive drugs.